Tommeurd W, Thueng-In K, Theerawatanasirikul S, Tuyapala N, Poonsuk S, Petcharat N
Antibodies (Basel). 2024; 13(3).
PMID: 39189238
PMC: 11348169.
DOI: 10.3390/antib13030067.
Li Q, Wubshet A, Wang Y, Heath L, Zhang J
Viruses. 2023; 15(3).
PMID: 36992505
PMC: 10059872.
DOI: 10.3390/v15030797.
Li P, Huang S, Zha J, Sun P, Li D, Bao H
Vet Res. 2022; 53(1):56.
PMID: 35804412
PMC: 9270804.
DOI: 10.1186/s13567-022-01072-7.
Pezzoni G, Calzolari M, Foglia E, Bregoli A, Nardo A, Sghaier S
Transbound Emerg Dis. 2022; 69(5):e2641-e2652.
PMID: 35686649
PMC: 9796625.
DOI: 10.1111/tbed.14611.
Xiao Y, Zhang S, Yan H, Geng X, Wang Y, Xu X
Front Vet Sci. 2021; 8:633706.
PMID: 33718472
PMC: 7947224.
DOI: 10.3389/fvets.2021.633706.
Development of an Indirect Chemiluminescence Immunoassay Using a Multiepitope Recombinant Protein To Specifically Detect Antibodies against Foot-and-Mouth Disease Virus Serotype O in Swine.
Liu W, Shao J, Zhang G, Chang Y, Ge S, Sun Y
J Clin Microbiol. 2020; 59(3).
PMID: 33328177
PMC: 8106706.
DOI: 10.1128/JCM.02464-20.
Molecular Mechanisms of Immune Escape for Foot-and-Mouth Disease Virus.
Yang B, Zhang X, Zhang D, Hou J, Xu G, Sheng C
Pathogens. 2020; 9(9).
PMID: 32899635
PMC: 7558374.
DOI: 10.3390/pathogens9090729.
Diagnostic and Epitope Mapping Potential of Single-Chain Antibody Fragments Against Foot-and-Mouth Disease Virus Serotypes A, SAT1, and SAT3.
Chitray M, Opperman P, Rotherham L, Fehrsen J, van Wyngaardt W, Frischmuth J
Front Vet Sci. 2020; 7:475.
PMID: 32851044
PMC: 7432252.
DOI: 10.3389/fvets.2020.00475.
Generation and characterisation of recombinant FMDV antibodies: Applications for advancing diagnostic and laboratory assays.
Shimmon G, Kotecha A, Ren J, Asfor A, Newman J, Berryman S
PLoS One. 2018; 13(8):e0201853.
PMID: 30114227
PMC: 6095514.
DOI: 10.1371/journal.pone.0201853.
Generation of mAbs to foot-and-mouth disease virus serotype A and application in a competitive ELISA for serodiagnosis.
Yang M, Xu W, Bittner H, Horsington J, Vosloo W, Goolia M
Virol J. 2016; 13(1):195.
PMID: 27894355
PMC: 5126828.
DOI: 10.1186/s12985-016-0650-z.
Characterization of monoclonal antibodies against foot-and-mouth disease virus serotype O and application in identification of antigenic variation in relation to vaccine strain selection.
Yang M, Xu W, Goolia M, Zhang Z
Virol J. 2014; 11:136.
PMID: 25085313
PMC: 4125342.
DOI: 10.1186/1743-422X-11-136.
Genetic heterogeneity in the leader and P1-coding regions of foot-and-mouth disease virus serotypes A and O in Africa.
Chitray M, de Beer T, Vosloo W, Maree F
Arch Virol. 2013; 159(5):947-61.
PMID: 24221247
PMC: 4010724.
DOI: 10.1007/s00705-013-1838-9.
Foot-and-mouth disease virus-like particles produced by a SUMO fusion protein system in Escherichia coli induce potent protective immune responses in guinea pigs, swine and cattle.
Guo H, Sun S, Jin Y, Yang S, Wei Y, Sun D
Vet Res. 2013; 44:48.
PMID: 23826638
PMC: 3720265.
DOI: 10.1186/1297-9716-44-48.
Effects of amino acid substitutions in the VP2 B-C loop on antigenicity and pathogenicity of serotype Asia1 foot-and-mouth disease virus.
Xue M, Wang H, Li W, Zhou G, Tu Y, Yu L
Virol J. 2012; 9:191.
PMID: 22963009
PMC: 3489780.
DOI: 10.1186/1743-422X-9-191.
Fine mapping of a foot-and-mouth disease virus epitope recognized by serotype-independent monoclonal antibody 4B2.
Yu Y, Wang H, Zhao L, Zhang C, Jiang Z, Yu L
J Microbiol. 2011; 49(1):94-101.
PMID: 21369985
DOI: 10.1007/s12275-011-0134-1.
Sequence-based prediction for vaccine strain selection and identification of antigenic variability in foot-and-mouth disease virus.
Reeve R, Blignaut B, Esterhuysen J, Opperman P, Matthews L, Fry E
PLoS Comput Biol. 2010; 6(12):e1001027.
PMID: 21151576
PMC: 3000348.
DOI: 10.1371/journal.pcbi.1001027.
Evaluation of genetically engineered derivatives of a Chinese strain of foot-and-mouth disease virus reveals a novel cell-binding site which functions in cell culture and in animals.
Zhao Q, Pacheco J, Mason P
J Virol. 2003; 77(5):3269-80.
PMID: 12584350
PMC: 149744.
DOI: 10.1128/jvi.77.5.3269-3280.2003.
Characterizing sequence variation in the VP1 capsid proteins of foot and mouth disease virus (serotype 0) with respect to virion structure.
Haydon D, Lea S, Fry L, Knowles N, Samuel A, Stuart D
J Mol Evol. 1998; 46(4):465-75.
PMID: 9541542
DOI: 10.1007/pl00006327.
Antigenic heterogeneity of a foot-and-mouth disease virus serotype in the field is mediated by very limited sequence variation at several antigenic sites.
Mateu M, Hernandez J, Martinez M, Feigelstock D, Lea S, Perez J
J Virol. 1994; 68(3):1407-17.
PMID: 8107204
PMC: 236594.
DOI: 10.1128/JVI.68.3.1407-1417.1994.
Characterization of monoclonal antibodies against a type SAT 2 foot-and-mouth disease virus.
Crowther J, Rowe C, Butcher R
Epidemiol Infect. 1993; 111(2):391-406.
PMID: 7691630
PMC: 2271387.
DOI: 10.1017/s0950268800057083.